《Table 1 Population, intervention, comparison and outcome characteristics of included studies》

  提示：宽带有限、当前游客访问压缩模式

本系列图表出处文件名：随高清版一同展现

《Effectiveness of taxanes over anthracyclines in neoadjuvant setting:A systematic-review and meta-analysis》

1. 获取 高清版本忘记账户？点击这里登录

1. 下载图表忘记账户？点击这里登录

pCR1:Pathological complete response to breast as well as axilla；pCR2:Pathological complete response to breast regardless of axilla；pCR3:Pathological complete response to breast allowing for ductal carcinoma in situ；NACT:Neoadjuvant Chemotherapy；OR:Overall

RCTs assessing the effectiveness of taxanes were sub-divided in two groups，i.e.，RCTs comparing taxanes alone to anthracyclines alone[20-23]（n=5）；and RCTs comparing taxanes and anthracyclines together to anthracyclines alone[4-6，9，24-30]（n=11）.Out of these 16 RCTs，10 RCTs assessed the effectiveness of docetaxel（3 RCT assessed the effectiveness of docetaxel vs doxorubicin along with other chemotherapy drugs however 7 RCTs assessed effectiveness of addition of docetaxel to anthracyclines based chemotherapy）.However，six RCTs assessed effectiveness of paclitaxel，more precisely two RCT assessed paclitaxel and four RCT assessed addition of paclitaxel to anthracyclines based chemotherapy.The details of Population，intervention and outcome are presented in Table 1.